Olanzapine



Indications and Reactions:

Role Indications Reactions
Primary
Schizophrenia 21.4%
Product Used For Unknown Indication 20.7%
Psychotic Disorder 10.3%
Bipolar Disorder 9.2%
Depression 6.7%
Schizophrenia, Paranoid Type 6.3%
Schizoaffective Disorder 3.3%
Bipolar I Disorder 2.7%
Anxiety 2.4%
Mania 2.4%
Agitation 2.1%
Mental Disorder 2.1%
Major Depression 2.1%
Hypertension 2.0%
Insomnia 1.3%
Constipation 1.1%
Schizophrenia, Catatonic Type 1.1%
Affective Disorder 0.9%
Dementia 0.9%
Epilepsy 0.8%
Weight Increased 17.8%
Sudden Cardiac Death 9.7%
Completed Suicide 6.9%
Death 6.0%
Pulmonary Embolism 5.4%
Overdose 4.7%
Psychotic Disorder 4.6%
Tremor 4.5%
Neutropenia 4.4%
Tachycardia 4.1%
Somnolence 4.0%
Hypothermia 3.6%
Neuroleptic Malignant Syndrome 3.6%
Sedation 3.6%
Toxicity To Various Agents 3.4%
Product Substitution Issue 2.9%
Suicide Attempt 2.9%
Suicidal Ideation 2.8%
Rhabdomyolysis 2.5%
Thrombocytopenia 2.5%
Secondary
Product Used For Unknown Indication 23.7%
Drug Use For Unknown Indication 16.0%
Schizophrenia 13.9%
Depression 6.4%
Psychotic Disorder 6.2%
Bipolar Disorder 5.9%
Schizoaffective Disorder 5.2%
Anxiety 3.0%
Schizophrenia, Paranoid Type 2.9%
Major Depression 2.2%
Agitation 2.1%
Insomnia 2.1%
Mania 1.8%
Self Injurious Behaviour 1.5%
Bipolar I Disorder 1.4%
Obsessive-compulsive Disorder 1.2%
Hypertension 1.2%
Feeling Abnormal 1.1%
Frustration 1.1%
Mental Disorder 1.1%
Weight Increased 19.3%
Completed Suicide 9.9%
Toxicity To Various Agents 7.2%
Respiratory Arrest 5.8%
Somnolence 4.9%
Tremor 4.8%
Suicide Attempt 4.5%
Tachycardia 4.4%
Sedation 4.2%
Overdose 4.0%
Delirium 3.9%
Neuroleptic Malignant Syndrome 3.6%
Vomiting 3.5%
Psychotic Disorder 3.4%
Dizziness 3.2%
Hyperhidrosis 2.9%
Hyponatraemia 2.7%
Irritability 2.7%
Rhabdomyolysis 2.5%
Syncope 2.5%
Concomitant
Product Used For Unknown Indication 18.4%
Schizophrenia 16.7%
Drug Use For Unknown Indication 13.2%
Depression 9.1%
Psychotic Disorder 6.0%
Bipolar Disorder 6.0%
Anxiety 4.1%
Schizophrenia, Paranoid Type 3.2%
Hiv Infection 2.9%
Hypertension 2.6%
Insomnia 2.6%
Pain 2.5%
Schizoaffective Disorder 2.4%
Agitation 2.3%
Affective Disorder 1.8%
Depressed Mood 1.6%
Mania 1.3%
Sleep Disorder 1.2%
Constipation 1.1%
Nausea 1.0%
White Blood Cell Count Decreased 10.0%
Vomiting 9.2%
Psychotic Disorder 8.7%
White Blood Cell Count Increased 7.9%
Weight Increased 7.2%
Weight Decreased 5.4%
Somnolence 4.5%
Suicidal Ideation 4.5%
Tremor 4.2%
Neutropenia 4.0%
Type 2 Diabetes Mellitus 4.0%
Overdose 3.7%
Pyrexia 3.6%
Tachycardia 3.6%
Thrombocytopenia 3.6%
Tardive Dyskinesia 3.5%
Withdrawal Syndrome 3.5%
Suicide Attempt 3.2%
Death 3.0%
Pancreatitis 2.9%
Interacting
Product Used For Unknown Indication 20.5%
Schizophrenia 11.6%
Bipolar Disorder 10.1%
Drug Use For Unknown Indication 7.1%
Mental Disorder 5.9%
Sedation 5.3%
Depression 4.5%
Schizophrenia, Catatonic Type 4.2%
Psychotic Disorder 3.6%
Suicide Attempt 3.6%
Dementia 3.3%
Hiv Infection 3.0%
Agitation 2.4%
Insomnia 2.4%
Major Depression 2.4%
Mania 2.4%
Pyrexia 2.4%
Hypertension 2.1%
Anorexia Nervosa 1.8%
Anxiety 1.8%
Drug Interaction 18.3%
Somnolence 13.5%
Sedation 9.6%
Oedema Peripheral 6.7%
Hyponatraemia 5.8%
Jaundice 5.8%
Toxicity To Various Agents 5.8%
Serotonin Syndrome 4.8%
Grandiosity 3.8%
Pancreatitis Acute 3.8%
Electrocardiogram Qt Prolonged 2.9%
Mental Status Changes 2.9%
Neuroleptic Malignant Syndrome 2.9%
Drug Ineffective 1.9%
Encephalopathy 1.9%
Hallucination 1.9%
Mental Retardation 1.9%
Miosis 1.9%
Neutropenia 1.9%
Off Label Use 1.9%